| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 303 | 344 | 360 | 392 | 335 | 356 | 350 | 309 | 353 | 404 | 435 | 454 | 412 | 405 | 105 | 367 | 337 | 342 | 402 | 385 | 354 | 426 | 212 | 301 | 364 | 347 | 302 | 279 | 320 | 314 |
| Expenses | 263 | 295 | 294 | 321 | 267 | 283 | 266 | 247 | 265 | 300 | 321 | 345 | 315 | 330 | 199 | 349 | 318 | 311 | 350 | 332 | 333 | 393 | 436 | 412 | 322 | 286 | 243 | 228 | 262 | 279 |
| EBITDA | 40 | 49 | 66 | 71 | 68 | 73 | 84 | 62 | 88 | 104 | 114 | 109 | 97 | 75 | -94 | 18 | 20 | 31 | 52 | 53 | 21 | 34 | -224 | -111 | 43 | 62 | 59 | 51 | 58 | 35 |
| Operating Profit % | 13 % | 14 % | 17 % | 17 % | 19 % | 19 % | 23 % | 17 % | 24 % | 25 % | 25 % | 22 % | 22 % | 18 % | -98 % | 3 % | 4 % | 8 % | 11 % | 13 % | 5 % | 8 % | -106 % | -38 % | 12 % | 18 % | 19 % | 17 % | 18 % | 11 % |
| Depreciation | 19 | 19 | 21 | 23 | 23 | 24 | 24 | 24 | 26 | 28 | 27 | 27 | 28 | 28 | 28 | 28 | 28 | 29 | 28 | 27 | 26 | 26 | 26 | 25 | 25 | 25 | 25 | 24 | 24 | 25 |
| Interest | 18 | 20 | 23 | 22 | 19 | 20 | 19 | 20 | 20 | 19 | 21 | 25 | 19 | 17 | 18 | 22 | 23 | 22 | 24 | 22 | 25 | 24 | 25 | 31 | 31 | 28 | 27 | 29 | 24 | 21 |
| Profit Before Tax | 3 | 9 | 22 | 26 | 27 | 29 | 41 | 18 | 42 | 57 | 66 | 57 | 50 | 30 | -140 | -31 | -31 | -19 | 1 | 5 | -29 | -17 | -275 | -167 | -14 | 8 | 8 | -2 | 11 | -10 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33 | -15 | -9 | 0 | 1 | -10 | 0 | 0 | 89 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 9 | 22 | 26 | 27 | 29 | 41 | 18 | 42 | 57 | 66 | 57 | 50 | 30 | -140 | 2 | -17 | -10 | 0 | 4 | -19 | -17 | -275 | -255 | -14 | 8 | 8 | -2 | 11 | -10 |
| EPS in ₹ | 0.23 | 3.47 | 8.96 | 10.17 | 10.29 | 11.21 | 16.00 | 6.78 | 15.75 | 19.21 | 18.47 | 15.57 | 13.95 | 8.27 | -38.93 | 0.53 | -4.56 | -2.77 | 0.12 | 1.05 | -5.43 | -4.77 | -72.07 | -70.93 | -3.50 | 2.54 | 2.03 | -0.93 | 2.46 | -2.36 |
Solara Active Pharma Sciences
Solara Active Pharma Sciences
519.00
-4.75
(-0.91%)
Market Cap
₹1,876.41 Cr
PE Ratio
318.93
Volume
41,362.00
Day High - Low
₹527.90 - ₹517.75
52W High-Low
₹882.80 - ₹442.80
Key Fundamentals
Market Cap
1,876.41 Cr
EPS
0.14
PB Ratio
1.64
Book Value
344.61
EBITDA
214.60
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals ROE Growth %
-
Debt to Equity
0.89
Actual
Company News
View All News
Solara Active Pharma Sciences announced successful closure of USFDA inspection at its Mangalore facility with Voluntary Action Indicated (VAI) classification, following inspection conducted between August 25-29, 2025. The company received two procedural Form FDA 483 observations and submitted formal response within timeline, with the agency issuing Establishment Inspection Report on November 18, 2025 and concluding the inspection as closed.
Solara Active Pharma Sciences reported a net loss of 101 million rupees in Q2, compared to a profit of 80 million rupees in the same period last year. Revenue declined to 3.14 billion rupees from 3.47 billion rupees year-over-year. EBITDA dropped to 347.3 million rupees from 613.1 million rupees, while EBITDA margin contracted to 11.08% from 17.67% in the previous year.
Solara Active Pharma Sciences Allots 8,040 Equity Shares Under Employee Stock Option Plan
Nov 06, 2025
Nov 06, 2025Solara Active Pharma Sciences Limited's Board of Directors approved the allotment of 8,040 equity shares of face value Rs. 10 each under the Solara Employee Stock Option Plan 2018. The allotment was approved at a Board Meeting on November 5, 2025. The company realized Rs. 30,15,000 from the exercise of these options. Following this allotment, the total paid-up capital increased from Rs. 44,47,93,723.50 to Rs. 44,48,74,123.50, with the number of fully paid equity shares rising from 3,61,63,267 to 3,61,71,307. The newly allotted shares rank pari-passu with existing equity shares. The diluted earnings per share pursuant to this issuance is Rs. 19 per share.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,810.30 | #1 4,34,351.61 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 76.30 | |
6,490.50 | 1,72,302.38 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 50.50 | |
3,730.40 | 1,26,253.69 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.46 | |
1,525.20 | 1,23,198.65 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.61 | |
1,249.30 | 1,04,268.30 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.75 | |
2,071.40 | 94,612.13 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 63.44 | |
937.25 | 94,309.28 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 41.16 | |
2,249.30 | 92,841.77 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 38.34 | |
1,235.80 | 71,775.46 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 67.24 | |
5,686.50 | 67,990.64 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 53.98 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-0.17 %
Net Income Growth
-100.09 %
Cash Flow Change
95.48 %
ROE
-100.08 %
ROCE
-125.90 %
EBITDA Margin (Avg.)
-339.34 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,822 | 1,960 | 2,154 | 2,614 | 2,945 | 2,899 | 2,351 | 2,232 |
| Fixed Assets | 1,086 | 1,218 | 1,397 | 1,382 | 1,356 | 1,364 | 1,268 | 1,193 |
| Current Assets | 608 | 648 | 672 | 1,058 | 1,239 | 1,188 | 801 | 729 |
| Capital Work in Progress | 72 | 40 | 41 | 88 | 239 | 239 | 256 | 280 |
| Investments | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
| Other Assets | 663 | 702 | 716 | 1,144 | 1,350 | 1,295 | 825 | 757 |
| Total Liabilities | 1,822 | 1,960 | 2,154 | 2,614 | 2,945 | 2,899 | 2,351 | 2,232 |
| Current Liabilities | 738 | 656 | 730 | 789 | 1,063 | 1,101 | 1,243 | 944 |
| Non Current Liabilities | 315 | 344 | 333 | 232 | 354 | 296 | 172 | 191 |
| Total Equity | 769 | 960 | 1,090 | 1,593 | 1,527 | 1,502 | 937 | 1,097 |
| Reserve & Surplus | 739 | 826 | 963 | 1,553 | 1,489 | 1,464 | 898 | 1,054 |
| Share Capital | 25 | 26 | 27 | 36 | 36 | 36 | 36 | 40 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 32 | 30 | -20 | 142 | -151 | -38 | -0 | -5 |
| Investing Activities | -86 | -113 | -359 | -106 | -243 | -81 | -4 | -37 |
| Operating Activities | 49 | 166 | 242 | 156 | -242 | 156 | 109 | 213 |
| Financing Activities | 68 | -23 | 97 | 93 | 334 | -113 | -106 | -181 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 44.11 % | 41.07 % | 41.07 % | 39.51 % | 39.71 % | 40.40 % | 40.40 % | 40.40 % | 40.97 % | 39.31 % | 37.19 % | 30.49 % | 30.49 % | 37.27 % | 37.27 % | 37.23 % | 37.94 % | 42.01 % | 42.01 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 15.80 % | 14.00 % | 14.25 % | 14.67 % | 14.63 % | 14.25 % | 13.58 % |
| DIIs | 3.72 % | 6.18 % | 5.55 % | 5.38 % | 3.39 % | 2.85 % | 2.56 % | 3.01 % | 2.22 % | 1.75 % | 1.75 % | 1.71 % | 2.97 % | 2.83 % | 3.38 % | 3.19 % | 2.61 % | 2.62 % | 2.69 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 14.76 % | 14.35 % | 13.84 % | 16.36 % | 17.41 % | 16.61 % | 17.28 % | 16.54 % | 16.23 % | 18.06 % | 19.84 % | 20.95 % | 20.15 % | 19.61 % | 18.83 % | 21.93 % | 23.07 % | 23.47 % | 24.01 % |
| Others | 37.41 % | 38.40 % | 39.53 % | 38.73 % | 39.48 % | 40.15 % | 39.76 % | 40.04 % | 40.58 % | 40.88 % | 41.22 % | 46.84 % | 30.59 % | 26.29 % | 26.28 % | 22.98 % | 21.74 % | 17.63 % | 17.70 % |
| No of Share Holders | 58,907 | 67,197 | 65,449 | 73,000 | 77,228 | 82,710 | 83,319 | 79,149 | 76,325 | 75,417 | 74,473 | 72,918 | 73,912 | 78,617 | 71,882 | 83,148 | 75,791 | 74,334 | 72,479 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 5 | 2 | 7 | 0.00 | 3 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 1.22 | 0.16 | 1.14 | 0.00 | 0.88 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Mar 2017 |  Change Of Name | NA | 25 Mar 2017 | 0.00 | 0.00 |
| 20 Aug 2021 |  Dividend | ₹ 3.00 /share | 18 Aug 2021 | 1,484.58 | 1,564.11 |
| 15 May 2024 |  Rights | 1:3 | 15 May 2024 | 465.01 | 503.40 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 694.40 | 736.35 |
| 21 Oct 2024 |  Quarterly Result Announcement | NA | 21 Oct 2024 | 748.90 | 809.60 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 652.85 | 678.80 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 482.35 | 576.30 |
| 25 Jul 2025 | Quarterly Result Announcement | NA | 25 Jul 2025 | 692.85 | 657.35 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 632.10 | 644.30 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 588.45 | 617.40 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 05, 2025
Nov 05, 2025General-UpdatesNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 05, 2025
Nov 05, 2025Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended September 30 2025.Nov 05, 2025
Nov 05, 2025Intimation Regarding The Grant Of ESOPNov 05, 2025
Nov 05, 2025Intimation About Appointment Of Mr. Mohanraj S As Chief Human Resources Officer (CHRO)Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 05, 2025
Nov 05, 2025Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 30, 2025
Oct 30, 2025Board Meeting Intimation for Quarter And Half Year Ended September 30 2025.Oct 29, 2025
Oct 29, 2025ESG Rating By CRISILOct 17, 2025
Oct 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-AllotmentOct 13, 2025
Oct 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 09, 2025
Oct 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement Under Regulation 30 SEBI (LODR) - ClarificationSep 26, 2025
Sep 26, 2025Clarification sought from Solara Active Pharma Sciences LtdSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 02, 2025
Sep 02, 2025Reg. 34 (1) Annual Report.Sep 02, 2025
Sep 02, 2025Notice Of The 8Th Annual General MeetingSep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Sep 01, 2025Intimation Regarding 100 Days Campaign - Saksham NiveshakAug 21, 2025
Aug 21, 2025Receipt Of Call Money Pursuant To The First Reminder Notice Issued For Payment Of First Call Money On The Outstanding Partly Paid-Up Rights Equity Shares Of The Company.Aug 16, 2025
Aug 16, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 26, 2025
Jul 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 25, 2025
Jul 25, 2025Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30 2025.Jul 25, 2025
Jul 25, 2025Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 25, 2025
Jul 25, 2025Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 21, 2025
Jul 21, 2025Board Meeting Intimation for Quarter Ended June 30 2025 Under SEBI Listing RegulationsJul 18, 2025
Jul 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 17, 2025
Jul 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 07, 2025
Jul 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 03, 2025
Jul 03, 2025Dispatch Of First Reminder Notice For Payment Of First Call MoneyJul 02, 2025
Jul 02, 2025Announcement under Regulation 30 (LODR)-Credit RatingJul 01, 2025
Jul 01, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 17, 2025
Jun 17, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.13% | 2 | 0.00% | -0.02% | |
 Aditya Birla Sun Life Flexi Cap Fund Direct-Growth | 0.10% | 0 | -0.01% | -0.01% | |
| Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth | 0.79% | 0 | -0.04% | -0.07% | |
| Aditya Birla Sun Life Mid Cap Direct Fund-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 31.17
ATR(14)
Less Volatile 23.39
STOCH(9,6)
Neutral 37.07
STOCH RSI(14)
Oversold 5.29
MACD(12,26)
Bearish -3.49
ADX(14)
Weak Trend 18.35
UO(9)
Bearish 43.12
ROC(12)
Downtrend And Accelerating -7.41
WillR(14)
Neutral -77.66
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
